Skip to main content
. 2015 Jan 7;35(1):234–244. doi: 10.1523/JNEUROSCI.3353-14.2015

Table 4.

SAG populations in morphants

Genotype Stage
26 hpf 36 hpf 42 hpf 48 hpf
Wild-type 1221 ± 196 μm2 (n = 16) 2048 ± 388 μm2 (n = 12) 2968 ± 258 μm2 (n = 15) 3273 ± 381 μm2 (n = 11)
fgf3 MO 1034 ± 95 μm2 (n = 13) 1018 ± 104 μm2 (n = 9) 1171 ± 68 μm2 (n = 14) 1150 ± 51 μm2 (n = 10)
fgf8 MO 790 ± 52 μm2 (n = 14) 840 ± 79 μm2 (n = 13) 1020 ± 82 μm2 (n = 11) 973 ± 102 μm2 (n = 13)
sox9a MO 736 ± 109 μm2 (n = 19) 1010 ± 127 μm2 (n = 19) 1019 ± 60 μm2 (n = 18) 1033 ± 48 μm2 (n = 20)
sox9b MO 787 ± 72 μm2 (n = 22) 785 ± 171 μm2 (n = 15) 828 ± 71 μm2 (n = 21) 1095 ± 228 μm2 (n = 13)
atoh1a MO 789 ± 76 μm2 (n = 13) 1064 ± 131 μm2 (n = 17) 1216 ± 277 μm2 (n = 13) 1292 ± 324 μm2 (n = 11)
atoh1b MO 969 ± 117 μm2 (n = 20) 2032 ± 204 μm2 (n = 18) 2355 ± 395 μm2 (n = 11) 2410 ± 247 μm2 (n = 13)

Listed is a summary of SAG areas at 26, 36, 42, and 48 hpf in both wild-type embryos and fgf3, fgf8a, sox9a, sox9b, atoh1a, or atoh1b morphants.